The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract
No, AOD-9604 is not FDA-approved for human therapeutic use
A detailed peptide program that's medically managed deserves a higher price, and your patients pay for that service
And as always when in doubt, consult a qualified healthcare provider or hormone optimization clinic
A typical program spans 4-8 weeks, followed by maintenance dosing (e.g., monthly B12 injections)
The role of BPC in the gastric juice is an important one